Oakley A J, Lo Bello M, Mazzetti A P, Federici G, Parker M W
The Ian Potter Foundation Protein Crystallography Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, Vic., Australia.
FEBS Lett. 1997 Dec 8;419(1):32-6. doi: 10.1016/s0014-5793(97)01424-5.
The diuretic drug ethacrynic acid, an inhibitor of pi class glutathione S-transferase, has been tested in clinical trials as an adjuvant in chemotherapy. We recently solved the crystal structure of this enzyme in complex with ethacrynic acid and its glutathione conjugate. Here we present a new structure of the ethacrynic-glutathione conjugate complex. In this structure the ethacrynic moiety of the complex is shown to bind in a completely different orientation to that previously observed. Thus there are at least two binding modes possible, an observation of great importance to the design of second generation inhibitors of the enzyme.
利尿药依他尼酸是一种π类谷胱甘肽S-转移酶抑制剂,已在临床试验中作为化疗辅助药物进行了测试。我们最近解析了该酶与依他尼酸及其谷胱甘肽共轭物复合物的晶体结构。在此,我们展示了依他尼酸-谷胱甘肽共轭物复合物的一种新结构。在该结构中,复合物的依他尼酸部分以与先前观察到的完全不同的方向结合。因此,至少存在两种可能的结合模式,这一发现对于该酶第二代抑制剂的设计具有重要意义。